Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−0.12EUR
−3.50 MEUR
4.60 MEUR
30.66 M
About ABIONYX PHARMA
Sector
CEO
Cyrille Tupin
Headquarters
Balma
Website
Founded
2005
ISIN
FR0012616852
ABIONYX Pharma SA engages in the in discovery and development of novel therapies for patients without existing or effective treatments. It specializes in the development of treatment for cardiovascular and metabolic disorders. The company was founded by Jean-Louis Dasseux and William F. Brinkerhoff on March 24, 2005 and is headquartered in Balma, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 609 is 1.06 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ABIONYX PHARMA SA stocks are traded under the ticker 609.
ABIONYX PHARMA SA is going to release the next earnings report on Sep 26, 2024. Keep track of upcoming events with our Earnings Calendar.
609 stock is 0% volatile and has beta coefficient of 0.27. Check out the list of the most volatile stocks — is ABIONYX PHARMA SA there?
Yes, you can track ABIONYX PHARMA SA financials in yearly and quarterly reports right on TradingView.
609 stock has fallen by 5.19% compared to the previous week, the month change is a 9.50% rise, over the last year ABIONYX PHARMA SA has showed a 42.70% decrease.
609 net income for the last quarter is −1.25 M EUR, while the quarter before that showed −2.25 M EUR of net income which accounts for 44.31% change. Track more ABIONYX PHARMA SA financial stats to get the full picture.
Today ABIONYX PHARMA SA has the market capitalization of 32.95 M, it has decreased by 5.75% over the last week.
No, 609 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 609 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABIONYX PHARMA SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABIONYX PHARMA SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABIONYX PHARMA SA stock shows the sell signal. See more of ABIONYX PHARMA SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ABIONYX PHARMA SA future price: according to them, 609 price has a max estimate of 10.50 EUR and a min estimate of 10.50 EUR. Read a more detailed ABIONYX PHARMA SA forecast: see what analysts think of ABIONYX PHARMA SA and suggest that you do with its stocks.